Skip to main contentSkip to navigation
Ovarian Cancer Research Alliance
Research Exchange
Donate

Investigator

Jiang Wu

West China Hospital Of Sichuan University

Research Interests

JWJiang Wu
Papers(1)
IL‐8 promotes cell mi…
Institutions(1)
West China Hospital O…

Papers

IL‐8 promotes cell migration through regulating EMT by activating the Wnt/β‐catenin pathway in ovarian cancer

AbstractInterleukin‐8 (IL‐8), as an inflammatory chemokine, has been previously shown to contribute to tumorigenesis in several malignancies including the ovarian cancer. However, little is known about how IL‐8 promotes the metastasis and invasion of ovarian cancers cells. In this study, we found that IL‐8 and its receptors CXCR1 and CXCR2 were up‐regulated in advanced ovarian serous cancer tissues. Furthermore, the level of IL‐8 and its receptors CXCR1 and CXCR2 expression were associated with ovarian cancer stage, grade and lymph node metastasis. In vitro, IL‐8 promoted ovarian cancer cell migration, initiated the epithelial‐mesenchymal transition (EMT) program and activated Wnt/β‐catenin signalling. However, when treated with Reparixin (inhibitor of both IL‐8 receptors CXCR1 and CXCR2), effect of both endogenous and exogenous IL‐8 was reversed. Together, our results indicated that IL‐8 triggered ovarian cancer cells migration partly through Wnt/β‐catenin pathway mediated EMT, and IL‐8 may be an important molecule in the invasion and metastasis of ovarian cancer.

1Works
1Papers
Ovarian NeoplasmsBiomarkers, TumorCell Line, TumorNeoplasms, Cystic, Mucinous, and Serous46, XX Disorders of Sex Development
Links & IDs
0000-0001-8434-5257
Ovarian Cancer Research Alliance

A global leader in the fight against gynecologic cancer

LIVING LAB
Join the Living LabOur TeamGovernance & EthicsShareable Resources
DISCOVERY LAB
Discovery LabHow It WorksUpcoming WebinarsContribute Data
ABOUT
About OCRAGet InvolvedMake a DonationContact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

PrivacyTermsAccessibility